Survey measures outsourcing highs, lows; Reese gets FDA warning;

> Survey: 55 percent of biopharma organizations outsource less than half of their global manufacturing, but 18 percent use outsourcing for at least 91 percent of their output. Release

> Over-the-counter drugmaker Reese Pharmaceutical has received an FDA warning letter for manufacturing and labeling violations. Story

> Capgemini: The pharmaceutical industry needs to address patient adherence in a more strategic and integrated part of its activities. Statement

> Systech International and Videojet say they are working with a big pharma manufacturer to implement Systech's Serialized Product Tracking solution on each of its packaging lines in Brazil.  Release

> German transdermal drug developer Labtec has opened a manufacturing facility in Europe for the production of transdermal drug delivery systems and oral dispersible films using its RapidFilm technology. Story

> CMO Lonza is planning a "state-of-the-art" GMP cleanroom for its viral-based therapeutics business in Houston, Texas. Report

> Sun Pharma says it will invest $100 million to expand and upgrade Taro Pharma's facilities. Item

> Schott has opened a primary pharmaceutical packaging facility in Zavolzhe, Russia. News

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.